We are live on ! Find out more
OM icon

Outset Medical
OM

152 hedge funds and large institutions have $1.26B invested in Outset Medical in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,263% more call options, than puts

Call options by funds: $9.99M | Put options by funds: $297K

67% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 24

66% more capital invested

Capital invested by funds: $760M → $1.26B (+$503M)

10% more funds holding

Funds holding: 138 → 152 (+14)

0.14% more ownership

Funds ownership: 6.63% → 6.77% (+0.14%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

Holders
152
Holders Change
+14
Holders Change %
+10.14%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
40
Increased
44
Reduced
44
Closed
24
Calls
$9.99M
Puts
$297K
Net Calls
+$9.69M
Net Calls Change
+$11.3M

Top Buyers

1
Barclays
Barclays
United Kingdom
+$8.27M
2
BG
Bellevue Group
Switzerland
+$8.01M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$6.52M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.84M
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$5.34M

Top Sellers

1
PHS
PFM Health Sciences
California
-$11.6M
2
Allspring Global Investments
Allspring Global Investments
North Carolina
-$11.3M
3
JP Morgan Chase
JP Morgan Chase
New York
-$9.94M
4
PVI
Pura Vida Investments
New York
-$8.46M
5
Jennison Associates
Jennison Associates
New York
-$6.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
151
Advisory Services Network
Georgia
$336 +$282 +1 New
PHS
152
PFM Health Sciences
California
– -$11.6M -48,628 Closed
Marshall Wace
153
Marshall Wace
United Kingdom
– -$3M -12,552 Closed
CSS
154
Cubist Systematic Strategies
Connecticut
– -$1.88M -7,874 Closed
WA
155
Wasatch Advisors
Utah
– -$1.54M -6,444 Closed
SEI Investments
156
SEI Investments
Pennsylvania
– -$1.28M -5,339 Closed
PI
157
PEAK6 Investments
Illinois
– -$1.21M -5,062 Closed
PP
158
PDT Partners
New York
– -$390K -1,634 Closed
Squarepoint
159
Squarepoint
New York
– -$322K -1,349 Closed
Man Group
160
Man Group
United Kingdom
– -$285K -1,193 Closed
GCP
161
GSA Capital Partners
United Kingdom
– -$257K -1,074 Closed
MAM
162
Must Asset Management
South Korea
– -$259K -1,049 Closed
Susquehanna International Group
163
Susquehanna International Group
Pennsylvania
– -$274K -973 Closed
SG Americas Securities
164
SG Americas Securities
New York
– -$128K -536 Closed
SCM
165
Silvant Capital Management
Georgia
– -$57K -240 Closed
DFCM
166
Dark Forest Capital Management
Puerto Rico
– -$31K -128 Closed
BWP
167
Baldwin Wealth Partners
Massachusetts
– -$8K -33 Closed
Northwestern Mutual Wealth Management
168
Northwestern Mutual Wealth Management
Wisconsin
– -$8K -33 Closed
IAMOG
169
Investors Asset Management of Georgia
Georgia
– -$8K -32 Closed
Group One Trading
170
Group One Trading
Illinois
– -$4K -19 Closed
TWA
171
TCI Wealth Advisors
Arizona
– -$3K -14 Closed
HI
172
Hoey Investments
Pennsylvania
– -$3K -13 Closed
VWM
173
Valley Wealth Managers
New Jersey
– -$564 -2 Closed
CAL
174
Capital Advisors Ltd
Ohio
– +$282 +1 New
3 4 5 6
7

OM Hedge Fund Activity: Q4 2022 in Review

152 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2022, worth a combined $1.26B — up 66% from $760M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new OM positions and 24 closed out — a net gain of 16 holders — while 44 added to existing stakes and 44 trimmed.

The largest buyer was Barclays, adding an estimated $8.27M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $11.6M sold.

  • 152 institutional investors held Outset Medical (OM) as of Q4 2022, up from 138 in Q3 2022.
  • Funds reported $1.26B of Outset Medical stock for Q4 2022, up 66% quarter-over-quarter.
  • 40 funds opened new Outset Medical positions in Q4 2022 and 24 closed out, a net change of +16 holders.
  • The largest Outset Medical buyer in Q4 2022 was Barclays, an estimated $8.27M added.
  • The largest Outset Medical seller in Q4 2022 was PFM Health Sciences, an estimated $11.6M sold.

Based on aggregated 13F filings for Q4 2022.